iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares SYNCOMF SYNCOM FORMULATIONS (INDIA) LIMITED INE312C01025 Board Meeting New 2025-05-19 Yes 2025-04-01 2025-05-21 Financial results Other business Audited Standalone And Consolidated Yearly March 2025 Intimation of holding 1/2025-26 Board Meeting for consideration and approval of the Standalone and Consolidated Audited Financial Results for Quarter and year ended 31st March, 2025 along with Statement of Assests and Liabilities and Cash Flow Statement for the half yearly ended 31st March, 2025